✦ LIBER ✦

Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: A pilot study of the Italian cooperative group GIMEMA

✍ Scribed by G. Avvisati; F. Mandelli; M. C. Petti; M. L. Vegna; A. Spadea; V. Liso; G. Specchia; C. Bernasconi; E. P. Alessandrino; C. Piatti; A. M. Carella

Book ID: 114791278
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 424 KB
Volume: 44
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1990.tb00389.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine in combination with a standa

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 197 KB